Cliff Asness's DXCM Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 444,631 shares of DexCom, Inc. (DXCM) worth $29.77 M, representing 0.02% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in DXCM, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2018, adding 928,220 shares. Largest reduction occurred in Q2 2019, reducing 1.59 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's DexCom (DXCM) Holding Value Over Time
Track share changes against reported price movement
Quarterly DexCom (DXCM) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2012 | +217,184 | Add 0.00% | 217,180 | $3.40 |
| Q2 2013 | +237,248 | Add 0.00% | 237,244 | $5.61 |
| Q3 2013 | -18,800 | Reduce 7.92% | 218,444 | $7.06 |
| Q4 2013 | +8,484 | Add 3.88% | 226,928 | $8.85 |
| Q1 2014 | +22,000 | Add 9.69% | 248,928 | $10.34 |
| Q2 2014 | +685,600 | Add 275.42% | 934,528 | $9.92 |
| Q3 2014 | -340,400 | Reduce 36.42% | 594,128 | $10.00 |
| Q4 2014 | -238,632 | Reduce 40.17% | 355,496 | $13.76 |
| Q1 2015 | -37,600 | Reduce 10.58% | 317,896 | $15.59 |
| Q2 2015 | -43,832 | Reduce 13.79% | 274,064 | $20.00 |
| Q3 2015 | +84,384 | Add 30.79% | 358,448 | $21.46 |
| Q4 2015 | +715,432 | Add 199.59% | 1.07 M | $20.48 |
| Q1 2016 | -864,368 | Reduce 80.49% | 209,512 | $16.98 |
| Q2 2016 | -61,880 | Reduce 29.54% | 147,632 | $19.83 |
| Q3 2016 | +6,456 | Add 4.37% | 154,088 | $21.92 |
| Q4 2016 | +110,208 | Add 71.52% | 264,296 | $14.93 |
| Q1 2017 | +32,548 | Add 12.31% | 296,844 | $21.18 |
| Q2 2017 | +90,844 | Add 30.60% | 387,688 | $18.29 |
| Q3 2017 | +6,800 | Add 1.75% | 394,488 | $12.23 |
| Q4 2017 | -146,468 | Reduce 37.13% | 248,020 | $14.35 |
| Q1 2018 | -139,684 | Reduce 56.32% | 108,336 | $18.54 |
| Q2 2018 | -11,224 | Reduce 10.36% | 97,112 | $23.75 |
| Q3 2018 | +472,132 | Add 486.17% | 569,244 | $35.76 |
| Q4 2018 | +928,220 | Add 163.06% | 1.5 M | $29.95 |
| Q1 2019 | +502,816 | Add 33.58% | 2 M | $29.61 |
| Q2 2019 | -1.59 M | Reduce 79.66% | 406,868 | $37.46 |
| Q3 2019 | -351,636 | Reduce 86.43% | 55,232 | $37.19 |
| Q4 2019 | -18,572 | Reduce 33.63% | 36,660 | $54.69 |
| Q1 2020 | +15,476 | Add 42.21% | 52,136 | $67.32 |
| Q2 2020 | +1,036 | Add 1.99% | 53,172 | $99.15 |
| Q3 2020 | +12,292 | Add 23.12% | 65,464 | $100.71 |
| Q4 2020 | -4,488 | Reduce 6.86% | 60,976 | $91.00 |
| Q1 2021 | -26,136 | Reduce 42.86% | 34,840 | $88.69 |
| Q2 2021 | -5,252 | Reduce 15.07% | 29,588 | $106.33 |
| Q3 2021 | -8 | Reduce 0.03% | 29,580 | $136.71 |
| Q4 2021 | +4 | Add 0.01% | 29,584 | $134.23 |
| Q1 2022 | +10,756 | Add 36.36% | 40,340 | $127.89 |
| Q2 2022 | +8,631 | Add 21.40% | 48,971 | $74.23 |
| Q3 2022 | +27,066 | Add 55.27% | 76,037 | $80.54 |
| Q4 2022 | -24,136 | Reduce 31.74% | 51,901 | $111.32 |
| Q1 2023 | +8,218 | Add 15.83% | 60,119 | $116.18 |
| Q2 2023 | +38,973 | Add 64.83% | 99,092 | $128.51 |
| Q3 2023 | -53,099 | Reduce 53.59% | 45,993 | $93.30 |
| Q4 2023 | +86,717 | Add 188.54% | 132,710 | $124.03 |
| Q1 2024 | +70,964 | Add 53.47% | 203,674 | $138.70 |
| Q2 2024 | -118,657 | Reduce 58.26% | 85,017 | $113.37 |
| Q3 2024 | +112,278 | Add 132.07% | 197,295 | $67.04 |
| Q4 2024 | +410,914 | Add 208.27% | 608,209 | $77.77 |
| Q1 2025 | +100,824 | Add 16.58% | 709,033 | $66.80 |
| Q2 2025 | -84,652 | Reduce 11.94% | 624,381 | $86.95 |
| Q3 2025 | -179,750 | Reduce 28.79% | 444,631 | $66.96 |
Cliff Asness's DexCom Investment FAQs
Cliff Asness first purchased DexCom, Inc. (DXCM) in Q4 2012, acquiring 217,180 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held DexCom, Inc. (DXCM) for 52 quarters since Q4 2012. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to DexCom, Inc. (DXCM) was in Q4 2018, adding 1,497,464 shares worth $44.85 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 444,631 shares of DexCom, Inc. (DXCM), valued at approximately $29.77 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, DexCom, Inc. (DXCM) represents approximately 0.02% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in DexCom, Inc. (DXCM) was 2,000,280 shares, as reported at the end of Q1 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.